Drug
Ze74 0282
Ze74 0282: highest development phase Phase 1, developed by Eilean Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eilean Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZE74-0282 NCT07529951 | Phase 1 | Polycythemia Vera (PV) |
Latest
No recent events.
Follow Ze74 0282 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.